Literature DB >> 323417

Demonstration of nuclear immunofluorescence in Rift Valley fever infected cells.

R Swanepoel, N K Blackburn.   

Abstract

Eosinophilic intranuclear filaments described previously in Rift Valley Fever infected cells, were shown to fluoresce specifically in an indirect technique with antiserum to the virus. Actinomycin D failed to suppress development of the filaments or replication of the virus.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 323417     DOI： 10.1099/0022-1317-34-3-557

Source DB:  PubMed          Journal:  J Gen Virol        ISSN： 0022-1317            Impact factor:   3.891


  21 in total

1.  The nonstructural protein NSs induces a variable antibody response in domestic ruminants naturally infected with Rift Valley fever virus.

Authors:  José-Carlos Fernandez; Agnès Billecocq; Jean Paul Durand; Catherine Cêtre-Sossah; Eric Cardinale; Philippe Marianneau; Michel Pépin; Noël Tordo; Michèle Bouloy
Journal:  Clin Vaccine Immunol       Date:  2011-11-09

Review 2.  Recent advances in the development of antiviral therapeutics for Rift Valley fever virus infection.

Authors:  Colm Atkins; Alexander N Freiberg
Journal:  Future Virol       Date:  2017-10-23       Impact factor: 1.831

3.  A ΩXaV motif in the Rift Valley fever virus NSs protein is essential for degrading p62, forming nuclear filaments and virulence.

Authors:  Normand Cyr; Cynthia de la Fuente; Lauriane Lecoq; Irene Guendel; Philippe R Chabot; Kylene Kehn-Hall; James G Omichinski
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-27       Impact factor: 11.205

4.  Rapamycin modulation of p70 S6 kinase signaling inhibits Rift Valley fever virus pathogenesis.

Authors:  Todd M Bell; Virginia Espina; Svetlana Senina; Caitlin Woodson; Ashwini Brahms; Brian Carey; Shih-Chao Lin; Lindsay Lundberg; Chelsea Pinkham; Alan Baer; Claudius Mueller; Elizabeth A Chlipala; Faye Sharman; Cynthia de la Fuente; Lance Liotta; Kylene Kehn-Hall
Journal:  Antiviral Res       Date:  2017-04-23       Impact factor: 5.970

5.  Nonstructural NSs protein of rift valley fever virus interacts with pericentromeric DNA sequences of the host cell, inducing chromosome cohesion and segregation defects.

Authors:  Z Mansuroglu; T Josse; J Gilleron; A Billecocq; P Leger; M Bouloy; E Bonnefoy
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

Review 6.  Advances in Rift Valley fever research: insights for disease prevention.

Authors:  A Desiree LaBeaud; James W Kazura; Charles H King
Journal:  Curr Opin Infect Dis       Date:  2010-10       Impact factor: 4.915

7.  The carboxy-terminal acidic domain of Rift Valley Fever virus NSs protein is essential for the formation of filamentous structures but not for the nuclear localization of the protein.

Authors:  F Z Yadani; A Kohl; C Préhaud; A Billecocq; M Bouloy
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

Review 8.  Molecular biology and genetic diversity of Rift Valley fever virus.

Authors:  Tetsuro Ikegami
Journal:  Antiviral Res       Date:  2012-06-16       Impact factor: 5.970

9.  Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention.

Authors:  Michel Pepin; Michele Bouloy; Brian H Bird; Alan Kemp; Janusz Paweska
Journal:  Vet Res       Date:  2010 Nov-Dec       Impact factor: 3.683

10.  Nuclear relocalization of polyadenylate binding protein during rift valley fever virus infection involves expression of the NSs gene.

Authors:  Anna Maria Copeland; Louis A Altamura; Nicole M Van Deusen; Connie S Schmaljohn
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.